Navigation Links
New Strategy To Tackle Rheumatic Heart Disease

People at risk of developing acute rheumatic fever (ARF) and rheumatic heart disease (RHD) should be actively screened and government health authorities notified of any new cases , according to new guidelines issued by the National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand.

Both caused by group A streptococcal bacteria, ARF and RHD are diseases of poverty that occur at world-record rates in Indigenous Australians.

Yet individual cases are often poorly managed, Professor Jonathan Carapetis of the Menzies School of Health Research, Darwin, and colleagues report in the latest issue of the Medical Journal of Australia.

Most jurisdictions with high rates of these diseases do not have formal control strategies in place, say the authors.

As well as active screening and legislated notification, the guidelines recommend new diagnostic and treatment criteria for ARF in high-risk populations, and the establishment of a coordinated control program for all at-risk regions of Australia.

In an editorial in the same issue of the MJA, Dr Alex Brown of the Baker Heart Research Institute, Alice Springs, and colleagues claim that at the very least, RHD control programs are needed in the Top End of the Northern Territory, Central Australia, northern Western Australia, and northern Queensland.

The authors say while it is critically important to ensure that people with ARF and RHD receive good treatment and preventive care, Australia must not lose sight of the fact that treatment of these diseases and secondary prevention programs are bandaid solutions to an underlying tragedy.

Ongoing disparities in the burden of ARF and RHD reflect a number of failures in the development and delivery of health and health-related services, they say.

Failure in primary prevention of ARF and RHD . . . reflects the failure to provide Indigenous communities with the appropriate type and level of housing and environmental conditions that all Australians should expect.


'"/>




Related medicine news :

1. Novel Strategy To Combat Alzheimer’s Disease
2. "Defensive Pessimism" Before Exam Results Not a Good Strategy
3. WHO Devises New Global Strategy To Fight Tuberculosis
4. HER-2 Positive Breast Cancer Patients May Benefit With a Combo Drug Strategy
5. West Nile Virus Can Be Tackled By New Strategy
6. Australia Set To Implement A national Strategy Tackle Cannabis Abuse
7. Clement Urged to Plot a National Pharmaceutical Strategy
8. New Preventive Strategy to Fight Childhood Obesity
9. Rae unveils Health-care Strategy
10. A Promising New Vaccination Strategy for Late-Stage Melanoma
11. Effective Strategy Against Bird flu-Spainish Flu Vaccine Raises Hopes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:10/2/2017)... Oct. 2, 2017 Halo Labs announces the European launch ... called the HORIZON at MIBio 2017 in Cambridge, U.K ... visible particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity ... novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
Breaking Medicine Technology: